NextPlat Corp (NASDAQ:NXPL) Short Interest Down 15.4% in September

NextPlat Corp (NASDAQ:NXPL) was the recipient of a significant decline in short interest in September. As of September 15th, there was short interest totalling 118,300 shares, a decline of 15.4% from the August 31st total of 139,900 shares. Approximately 1.3% of the company’s stock are sold short. Based on an average daily trading volume, of 120,000 shares, the days-to-cover ratio is currently 1.0 days.

NextPlat Stock Performance

Shares of NXPL opened at $1.42 on Monday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.93 and a current ratio of 3.30. NextPlat has a twelve month low of $0.99 and a twelve month high of $2.68. The firm’s 50 day moving average price is $1.22 and its two-hundred day moving average price is $1.24. The firm has a market cap of $26.66 million, a P/E ratio of -5.68 and a beta of 0.89.

NextPlat (NASDAQ:NXPL) last announced its quarterly earnings data on Wednesday, August 14th. The company reported $0.24 EPS for the quarter. NextPlat had a negative net margin of 7.59% and a positive return on equity of 29.57%. The business had revenue of $16.99 million for the quarter.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.